https://orcid.org/0000-0003-0029-5446
References
- Rachmilewtiz E, Giardina P. How I treat thalassemia. Blood. 2011;118:3479–3488. doi:10.1182/blood-2010-08-300335
- Thein SL. Pathophysiology of β-thalassemia-A guide to molecular therapies. Am Soc Hematol Educ Prog. 2005;2005:31–37. doi:10.1182/asheducation-2005.1.31
- Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, et al. Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metab. 2003;88:3966–3972. doi:10.1210/jc.2002-021548
- Kremastinos DT, Farmakis D. Iron overload cardiomyopathy in clinical practice. Circ. 2011;124:2253–2263. doi:10.1161/CIRCULATIONAHA.111.050773
- Hershko C. Pathogenesis and management of iron toxicity in thalassemia. Ann NY Acad Sci. 2010;1202:1–9. doi:10.1111/j.1749-6632.2010.05544.x
- Papanikolaou G, Pantopoulos K. Pantopoulos iron metabolism and toxicity. App Toxicol Pharmacol. 2005;202:199–211. doi:10.1016/j.taap.2004.06.021
- Voskaridou E, Tepos E. New insights into the pathophysiology and management of osteoporosis in Patients with beta-thalassemia. Br J Haematol. 2004;127:127–139. doi:10.1111/j.1365-2141.2004.05143.x
- Pootrakul P, Hungsprenges S, Fucharoen S, et al. Relation between erythropoiesis and bone metabolism in thalassemia. N Eng J Med. 1981;304:1470–1473. doi:10.1056/NEJM198106113042406
- Michelson J, Cohen A. Incidence and treatment of fractures in thalassemia. J Orthop Trauma. 1988;2:29–32. doi:10.1097/00005131-198802000-00007
- Jensen CE, Tuck BC, Agnew JE, et al. High prevalence of low bone mass in thalassemia major. Brit J Haematol. 1998;103:911–915. doi:10.1046/j.1365-2141.1998.01108.x
- Vichinsky EP. The morbidity of bone disease in thalassemia. Ann NY Acad Sci. 1998;850:344–348. doi:10.1111/j.1749-6632.1998.tb10491.x
- Abdollah SA, Bekheirnia MR, Kamgar M, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord. 2003;3:1–6.
- Hashemieh M, Azarkeivan A, Radfar M, et al. Prevalence of osteoporosis among thalassemia patients with thalassemia clinic from Zafar adult, Iran. J Iran Blood Cancer. 2014;6:143–148.
- Tirtarahardja G, Setyohadi B, Weynand LS, Zhou Q. Bone mineral density reference values for Indonesian men and women; 2006. Available from: https://www.researchgate.net/publication/297712953. Accessed March 10, 2016.
- DiStefano M, Chiabotto P, Roggia C, Garofalo F, Laura R. Bone mass and metabolism in thalassemic children and adolescents treated with different iron-chelating drugs. J Bone Miner Metab. 2004;22:53–57. doi:10.1007/s00774-003-0449-z
- Grampp S, Genant HK, Mathur A, et al. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res. 1997;12:697–711. doi:10.1359/jbmr.1997.12.5.697
- Merchant R, Udani A, Puri V, et al. Evaluation of osteopathy in thalassemia by bone mineral densitometry and biochemical indices. Indian J Pediatr. 2010;77:987–991. doi:10.1007/s12098-010-0158-2
- Piga A, Longo F, Duca L, et al. High nontransferrin bound iron levels and heart disease in thalassemia major. Am J Hematol. 2009;84:29–33. doi:10.1002/ajh.21317
- Ogilvie C, Fitzsimons K, Fitzsimons E. Serum ferritin values in primary care: high values are overlooked. J Clin Pathol. 2010;63:1124–1126. doi:10.1136/jcp.2010.083188
- Li CK, Chik KW, Lam CWK, et al. Liver disease in transfusion-dependent thalassemia major. Arch Dis Child. 2002;86:344–347. doi:10.1136/adc.86.5.344
- Tenggara JB, Atmakusuma TD, Yulisa ND, Abdullah M. Correlation of transferrin saturation and serum ferritin with bone mass density in adult transfusion dependent beta thalassemia patients. Thesis. 2016.